Seeing Is Believing
OCX is currently covered by 5 analysts with an average price target of $15.55. This is a potential upside of $13.09 (532.11%) from yesterday's end of day stock price of $2.46.
OncoCyte Corp's activity chart (see below) currently has 23 price targets and 34 ratings on display. The stock rating distribution of OCX is 72.73% BUY and 27.27% HOLD.
Analysts average stock forecasts to be materialized ratio is 41.52% with an average time for these price targets to be met of 58.45 days.
Highest price target for OCX is $5, Lowest price target is $3, average price target is $15.55.
Most recent stock forecast was given by MIKE MATSON from NEEDHAM on 24-Apr-2024. First documented stock forecast 24-Mar-2016.
Currently out of the existing stock ratings of OCX, 8 are a BUY (72.73%), 3 are a HOLD (27.27%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4.25
$1.79 (72.76%)
3.6
2 days ago
2/4 (50%)
$1.79 (72.76%)
58
Buy
5
$2.54 (103.25%)
5
11 days ago
0/4 (0%)
$2.47 (97.63%)
Hold
3
$0.54 (21.95%)
3.5
5 months 13 days ago
2/5 (40%)
$0.24 (8.70%)
2
Hold
10
$7.54 (306.50%)
80
1 years 4 months 25 days ago
1/4 (25%)
$0.5 (5.26%)
204
Buy
25
$22.54 (916.26%)
62
1 years 11 months 2 days ago
1/2 (50%)
$5.31 (26.97%)
16
What is OCX (OncoCyte Corp) average time for price targets to be met?
Which analyst has the current highest performing score on OCX (OncoCyte Corp) with a proven track record?
Which analyst has the most public recommendations on OCX (OncoCyte Corp)?
Which analyst is the currently most bullish on OCX (OncoCyte Corp)?
Which analyst is the currently most reserved on OCX (OncoCyte Corp)?